Steven Denbaars, Director at Aeluma, Inc. (ALMU), sold 25,000 shares at $19.56 ($506K) on 2026-05-19, disclosed to the SEC on 2026-05-21.
Scheduled sale ($506k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.56 | 7,415 | $145K | 28.7% |
| 2 | $20.61 | 5,085 | $105K | 20.7% |
| 3 | $20.40 | 11,558 | $236K | 46.6% |
| 4 | $21.30 | 942 | $20K | 4.0% |
| Total | $20.23 avg | 25,000 | $506K | 100% |
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| ALMU | SELL | 2026-08-28 | $346K | — | Filing → |
| PrivatePalomino Laboratories Inc. | BUY |
| 2026-04-20 |
| $50K |
| — |
| Filing → |
| ALMU | SELL | 2026-02-27 | $418K | — | Filing → |
| ALMU | BUY | 2025-05-23 | $100K | — | Filing → |
| AKTS | SELL | 2023-08-22 | $13K | — | Filing → |